KR20070095754A - 신규 화합물, 그것을 함유하는 약학 조성물, 및 그것을사용하는 방법 - Google Patents

신규 화합물, 그것을 함유하는 약학 조성물, 및 그것을사용하는 방법 Download PDF

Info

Publication number
KR20070095754A
KR20070095754A KR1020067026941A KR20067026941A KR20070095754A KR 20070095754 A KR20070095754 A KR 20070095754A KR 1020067026941 A KR1020067026941 A KR 1020067026941A KR 20067026941 A KR20067026941 A KR 20067026941A KR 20070095754 A KR20070095754 A KR 20070095754A
Authority
KR
South Korea
Prior art keywords
compound
pharmaceutical composition
fas
alkyl
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020067026941A
Other languages
English (en)
Korean (ko)
Inventor
질 엠. 스튜디반트
크레이그 에이. 타운센드
수잔 엠. 매드그할치
Original Assignee
파스젠, 엘엘씨.
더 존스 홉킨스 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파스젠, 엘엘씨., 더 존스 홉킨스 유니버시티 filed Critical 파스젠, 엘엘씨.
Publication of KR20070095754A publication Critical patent/KR20070095754A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
KR1020067026941A 2004-05-26 2005-05-25 신규 화합물, 그것을 함유하는 약학 조성물, 및 그것을사용하는 방법 Withdrawn KR20070095754A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57463904P 2004-05-26 2004-05-26
US60/574,639 2004-05-26

Publications (1)

Publication Number Publication Date
KR20070095754A true KR20070095754A (ko) 2007-10-01

Family

ID=35463277

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067026941A Withdrawn KR20070095754A (ko) 2004-05-26 2005-05-25 신규 화합물, 그것을 함유하는 약학 조성물, 및 그것을사용하는 방법

Country Status (13)

Country Link
US (1) US20090005435A1 (cg-RX-API-DMAC7.html)
EP (1) EP1758577A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008500363A (cg-RX-API-DMAC7.html)
KR (1) KR20070095754A (cg-RX-API-DMAC7.html)
CN (1) CN101022792A (cg-RX-API-DMAC7.html)
AU (1) AU2005249437A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0510397A (cg-RX-API-DMAC7.html)
CA (1) CA2568639A1 (cg-RX-API-DMAC7.html)
IL (1) IL179530A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06013687A (cg-RX-API-DMAC7.html)
RU (1) RU2006146051A (cg-RX-API-DMAC7.html)
WO (1) WO2005117590A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700024B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014248A2 (en) * 2005-07-26 2007-02-01 Johns Hopkins University Method of reducing food intake
AU2007300627B2 (en) * 2006-09-22 2012-02-16 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
KR101640263B1 (ko) * 2007-10-05 2016-07-15 젠자임 코포레이션 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
WO2014039769A1 (en) * 2012-09-07 2014-03-13 Janssen Pharmaceutica Nv Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
CA2968288A1 (en) 2014-11-20 2016-05-26 Vib Vzw Means and methods for treatment of early-onset parkinson's disease
CN114980740A (zh) 2020-01-23 2022-08-30 巴斯夫欧洲公司 用于农业化学配制剂的新型添加剂
CN116507203B (zh) 2020-10-27 2026-08-07 巴斯夫欧洲公司 农药微乳剂组合物
CA3207197A1 (en) 2021-02-05 2022-08-11 Murat Mertoglu Liquid herbicidal compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
MXPA04007556A (es) * 2002-02-08 2005-12-05 Univ Johns Hopkins Med Estimulacion de cpt-1 como medio para reducir peso.
US7649012B2 (en) * 2002-07-09 2010-01-19 Fasgen, Inc. Compounds, pharmaceutical compositions containing same, and methods of use for same

Also Published As

Publication number Publication date
WO2005117590A3 (en) 2006-07-27
WO2005117590A2 (en) 2005-12-15
ZA200700024B (en) 2008-06-25
JP2008500363A (ja) 2008-01-10
AU2005249437A1 (en) 2005-12-15
RU2006146051A (ru) 2008-07-10
EP1758577A2 (en) 2007-03-07
BRPI0510397A (pt) 2007-11-13
US20090005435A1 (en) 2009-01-01
EP1758577A4 (en) 2010-05-05
CA2568639A1 (en) 2005-12-15
IL179530A0 (en) 2007-05-15
MXPA06013687A (es) 2007-10-18
CN101022792A (zh) 2007-08-22

Similar Documents

Publication Publication Date Title
US7649012B2 (en) Compounds, pharmaceutical compositions containing same, and methods of use for same
US20060241177A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
US20090005435A1 (en) Novel Compounds, Pharmaceutical Compositions Containing Same, and Methods of Use for Same
US20100168176A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
US20100029752A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
US20100029761A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HK1112837A (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HK1086485B (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20061221

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid